A pharmacological study of N-( -(p-l-hydroxypropyl)phenoxyethyl)-l-phenyl-2-aminopropane.
D000433:1-Propanol / Q000494:pharmacology; D000818:Animals; D001341:Autonomic Nervous System / Q000187:drug effects; D002245:Carbon Dioxide / Q000378:metabolism; D002302:Cardiac Output / Q000187:drug effects; D004285:Dogs; D005260:Female; D006321:Heart / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects*; D007022:Hypotension / Q000139:chemically induced; D008297:Male; D009206:Myocardium / Q000378:metabolism; D010100:Oxygen / Q000097:blood; D010101:Oxygen Consumption / Q000187:drug effects; D010627:Phenethylamines / Q000494:pharmacology*; D010636:Phenols / Q000494:pharmacology; D012119:Respiration / Q000187:drug effects; D014655:Vascular Resistance / Q000187:drug effects; D014665:Vasodilator Agents / Q000494:pharmacology*; D014691:Ventilation / Q000187:drug effects
D010627:Phenethylamines; D010636:Phenols; D014665:Vasodilator Agents; D002245:Carbon Dioxide; D000433:1-Propanol; D010100:Oxygen